Equity Details
Price & Market Data
Price: $408.0
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $3,419,702,528
Daily Volume: 0
Performance Metrics
1 Week: -6.49%
1 Month: -6.49%
3 Months: -6.49%
6 Months: 17.92%
1 Year: 24.47%
YTD: %
About Virbac SA (VRBCF)
Your daily market report for Virbac SA (VRBCF). Price: 408.0, daily change: $0.00 / 0.00%. Market cap: 3,419,702,528. Full performance analysis from YTD to 52-week.
Company Details
Employees: 6442
Sector: Health technology
Industry: Biotechnology
Country: France
Details
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. The company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.